Nav: Home

Synthetic carbohydrates against autoimmune diseases

April 17, 2017

Researchers are developing an innovative approach for the treatment of a rare autoimmune disease of the peripheral nervous system, using a type of molecular sponge consisting of carbohydrates to remove pathogenic antibodies from the bloodstream. Developed to treat anti-MAG neuropathy, the approach also has potential applications for the treatment of other autoimmune diseases. Scientists from the University of Basel and University Hospital Basel have reported their findings in the scientific journal PNAS.

Patients with anti-MAG neuropathy predominantly suffer from sensory loss in their arms and legs, neuropathic pain, and a loss of coordination that can substantially impair mobility. Through progressive damage to the peripheral nerves, the patients become increasingly disabled in their day-to-day lives until they require full-time care.

The disease is diagnosed based on the presence of blood serum autoantibodies that bind to the myelin-associated glycoprotein (MAG) in the peripheral nervous system. These anti-MAG antibodies have long been recognized as the cause of the disease. Furthermore, a reduction of the antibody concentration in the blood leads to an improvement in the symptoms.

To date, no approved treatment is available that specifically targets these autoantibodies. Current therapies are directed to suppress the immune response; they are inefficient and in some cases cause serious side effects.

Artificial molecule as a sponge

Basel-based researchers are thus working on a new treatment approach with customized synthetic glycopolymers that act like a sponge on the harmful autoantibodies. The glycopolymer mimicks the section of the MAG protein the anti-MAG antibodies are binding to.

The scientists could show in vitro that the glycopolymer neutralizes the disease-causing antibodies in patient sera and more importantly, that the anti-MAG antibodies could be effectively removed in immunized mice.

Potential for other autoimmune diseases

This new treatment method offers significant potential not only for an antigen-specific treatment of anti-MAG neuropathy but also for other antibody-mediated autoimmune diseases.

Currently, only fragmentary knowledge of the antigens in many autoimmune diseases is available. Antigen-specific therapies are therefore very difficult to develop. "The use of our glycopolymers opens up new possibilities for the treatment of diseases where anti-glycan antibodies play a role," says study director Professor Beat Ernst from the Department of Pharmaceutical Sciences at the University of Basel. Examples of such diseases include multifocal motor neuropathy or Guillain-Barré syndrome.

Collaboration with spin-off

These findings are the result of a joint project between the University of Basel's Department of Pharmaceutical Sciences and Polyneuron Pharmaceuticals AG, a University of Basel spin-off founded by Dr. Ruben Herrendorff, Professor Andreas Steck and Professor Beat Ernst in 2014. The project was funded by the Commission for Technology and Innovation (CTI), the Gebert Rüf Foundation, and the Neuromuscular Research Association Basel.

Polyneuron Pharmaceuticals AG is currently preparing for a clinical trial with the glycopolymer drug for the treatment of anti-MAG neuropathy.

University of Basel

Related Autoimmune Diseases Articles:

Cellular stress increases the probability of developing autoimmune diseases
Researchers found that cellular stress enhances the activation of certain type of immune cells with implications in many chronic inflammatory conditions.
Smoking decreases MAIT cells, implicated in the pathology of autoimmune diseases
New research published in the May 2017 issue of the Journal of Leukocyte Biology provides another reason why smoking tobacco is harmful.
Researchers describe ultrasensitive detection of protein linked to multiple autoimmune diseases
Researchers in France have developed a new method that will allow doctors to detect minute amounts of a protein called interferon- in patient samples.
Synthetic carbohydrates against autoimmune diseases
Researchers are developing an innovative approach for the treatment of a rare autoimmune disease of the peripheral nervous system, using a type of molecular sponge consisting of carbohydrates to remove pathogenic antibodies from the bloodstream.
Cargo-carrying red blood cells alleviate autoimmune diseases in mice
Using red blood cells modified to carry disease-specific antigens, a team of scientists from Whitehead Institute and Boston Children's Hospital have prevented and alleviated two autoimmune diseases -- multiple sclerosis (MS) and type 1 diabetes --i n early stage mouse models.
More Autoimmune Diseases News and Autoimmune Diseases Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Teaching For Better Humans
More than test scores or good grades — what do kids need to prepare them for the future? This hour, guest host Manoush Zomorodi and TED speakers explore how to help children grow into better humans, in and out of the classroom. Guests include educators Olympia Della Flora and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#535 Superior
Apologies for the delay getting this week's episode out! A technical glitch slowed us down, but all is once again well. This week, we look at the often troubling intertwining of science and race: its long history, its ability to persist even during periods of disrepute, and the current forms it takes as it resurfaces, leveraging the internet and nationalism to buoy itself. We speak with Angela Saini, independent journalist and author of the new book "Superior: The Return of Race Science", about where race science went and how it's coming back.